Swine influenza virus (SIV) is one of the most common respiratory viruses affecting swine. Swine influenza is present worldwide, and in the USA approximately 25-33% of slaughter pigs (6-7 months old) and 45% of 2-year-old breeding stock have anti-H1N1 SIV antibodies. 2 Nearly all swine influenza in the USA is caused by H1N1 viruses. Only H1N1 viruses have been isolated from swine in the USA, although serologic studies indicate a low prevalence of antibody to H3N2 influenza virus. 2 In 1994, infection with SIV was detected by virus isolation (VI), by fluorescent antibody examination (FA), or by recognition of characteristic lesions in 180 of approximately 1,800 cases of swine respiratory disease submitted to Iowa State University Veterinary Diagnostic Laboratory (ISU-VDL).Rapid, reliable methods for the diagnosis of influenza in swine are essential for veterinary diagnostic laboratories serving the swine industry. Currently, diagnosis is based on characteristic clinical signs, gross and microscopic lesions, results of FA examination of frozen tissue sections, and results of VI. Each diagnostic method has certain disadvantages. Clinical signs and gross and microscopic lesions may be atypical. The multifocal distribution of SIV lesions may result in sample-to-sample variation, which can affect the results of histopathologic and FA examinations. Other factors limiting the effectiveness of the FA test in demonstrating SIV antigen include the brief time postinfection that virus is present in the lung and the need to have fresh tissues with minimal autolytic changes available for examinations. In addition, use of a fluorescence microscope is necessary, and the stained slides are not permanent records because fluorescence fades quickly.The immunohistochemical (IHC) test detects virus in formalin-fixed, paraffin-embedded tissues and is relatively rapid, inexpensive, and easy to perform. The location of the virus in airway epithelial cells, macrophages, and pneumocytes can be directly visualized and associated with characteristic lesions by light microscopy. The IHC test also may be useful for performing retrospective studies when fresh tissue may no longer be available, because antigens detected by this method have been shown to be stable in paraffin for 10 years. 3 The purpose of this study was to develop an IHC test for detection of SIV in formalin-fixed tissue. A similar
The wild type influenza strain A/Aichi/2/68 (H3N2), when disrupted with SDS and electrophoresed on cellulose acetate paper, yielded two separate neuraminidases, NA(H+) and NA(H-). These enzymes after extraction were biologically active and possessed different specific activities. Enzyme NA(H+) possessed neuraminidase as well as hemagglutinin activities whereas enzyme NA(H-) demonstrated only neuraminidase activity. Similar results were obtained when the Aichi strain was treated with Tween-ether and the two enzymes were separated by affinity chromatography. Techniques used failed to separate the hemagglutinin activity from neuraminidase NA(H+). These results suggest that the dual activity present in enzyme NA(H+) may be characteristic of this protein. Both enzymes are antigenically different and are apparently present as distinct entities in the Aichi strain. Experiments showed that only enzyme NA(H-) of the Aichi strain was incorporated into the hybrid X-32 virus during genetic recombination.
A ribonuclease activity associated with influenza virus has been purified to homogeneity. This preparation is free of DNAase, phosphodiesterase, and phosphatase activities. The purified enzyme has a pH optima of 7.0 at 37 degrees C, and moves as a single band on sodium dodecyl sulfate - polyacrylamide gel with an estimated molecular weight of 84 000.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.